About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials | 4,236 Studies Recruiting

Clinical TrialsSchizophrenia

Schizophrenia Clinical Trials

Browse 4,236 clinical trials for schizophrenia. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3281-3300 of 4,236 trials

Not yet recruitingEfficacy of Mindfulness in PREventing Progression to Psychosis in Individuals With an Ultra High Risk for PsychosisThe main objective is to evaluate the efficacy of a group-based mindfulness therapy programme in reducing distress associated with symptoms of UHR (Ultra High Risk) or FEP (first…NCT06870305·Brest and 1 other UnknownEffect of Memantine on ERP in Early Schizophrenia and Healthy SubjectsPatients with schizophrenia are deeply affected by the positive symptoms, negative symptoms and cognitive impairment.NCT02233556·Taipei, Taiwan

Related Searches

Data from ClinicalTrials.govTerms

CompletedEnhancing Synaptic Plasticity and Cognition in SchizophreniaTo explore: (a) if physical exercise (sports) combined with cognitive training leads to (superior) improvement of cognition in schizophrenia compared to sports or cognitive…NCT01776112·Göttingen, Lower Saxony

CompletedA Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable SchizophreniaThe purpose of this study is to evaluate safety, tolerability and pharmacokinetics (explores what the body does to the drug) of JNJ-37822681 in participants with stable…NCT01812642·Antwerp and 5 others

CompletedLurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable SchizophreniaLurasidone HCl is a compound being developed for the treatment of schizophrenia.NCT00641745·Little Rock, Arkansas and 72 others

CompletedStudy Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With SchizophreniaTo evaluate the safety and tolerability of multiple doses of PF-02545920 subjects with schizophrenia or schizo-affective disorder who are currently clinically stable and to…NCT00463372·George

CompletedSmoking Cessation Study for Patients With Schizophrenia or Schizoaffective DisorderStudy will determine whether patients with schizophrenia or schizoaffective disorder can be helped to quit smoking safely while using varenicline and receiving smoking cessation…NCT00644969·Aurora, Colorado and 13 others

CompletedEfficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute SchizophreniaThe purpose of this study is to determine the safety and efficacy of iloperidone compared to placebo and an active comparator in the treatment of patients with schizophrenia in…NCT00254202·Little Rock, Arkansas and 41 others

CompletedThe Evaluation of the Use of a New Physical Health PlanPeople suffering from psychotic illnesses (e.g. schizophrenia) have poorer physical health than the general population.NCT03178279·London

TerminatedAdjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of SchizophreniaThe primary purpose of this study is to determine whether SPD489 40 mg, 100 mg, and 160 mg are effective and safe in the treatment of Negative Symptoms of Schizophrenia (NSS).NCT01738698·Irving, Texas

CompletedStudy by Electroencephalography of the Link Between the Lack of Self-compassion and the Disorder of Empathy in SchizophreniaThis research project focuses on a fundamental element of the psychopathology of schizophrenia, that is to say, the disorders of self-awareness and on the functional alterations…NCT05464563·Poitiers

CompletedMolecular Genetic Study of Schizophrenia: Parent-Offspring TriosSchizophrenia is a chronic and devastating major psychiatric disorder. Family, twin, and adoption studies indicated that schizophrenia has a significant genetic component.NCT00155506

CompletedCommunity Reinforcement Approach and Family Training for Substance Use in Early Psychosis InterventionThe goal of this pilot feasibility and proof of concept study is to evaluate whether Community Reinforcement and Family Training (CRAFT) as adapted for group delivery in an early…NCT05300633·Toronto, Ontario

CompletedEfficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic TreatmentThe objective of this study is to demonstrate that there is a benefit in switching chronic schizophrenic patients from conventional antipsychotic to olanzapine in terms of…NCT00191555·Aix-en-Provence and 61 others

WithdrawnTargeted Intervention Study of DTMS on Impaired Insight in Early PsychosisImpaired insight is a key factor in the conversion of high-risk individuals to schizophrenia, but there is a lack of targeted interventions.NCT04513132·Shanghai, Shanghai Municipality

CompletedPatient Guided Psychiatric AdmissionsTo meet the requirement for increased patient involvement, several Community Mental Health Centres (CMHC) have initiated a service called "patient-guided admissions".NCT01133587·Trondheim

CompletedEcologically Valid Virtual Tasks vs Paper-pencil Methods in Cognitive Rehabilitation in Patients With Schizophrenia and DepressionSchizophrenia is heterogeneous and often disabling a disease that affects 1% of the population.NCT04598906·Fryštát

RecruitingEnergetics and Glutamate in SchizophreniaThe goal of this case-control study is to compare brain glutamate, glucose utilisation, lactate production and brain activity in healthy volunteers and people with a diagnosis of…NCT06236048·London

TerminatedOlanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic SubjectsThe purpose of this study is to determine if zonisamide SR will prevent weight gain in schizophrenic subjects who take olanzapine (Zyprexa)NCT00734435·National City, California and 8 others

UnknownBridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance ImagingThe human brain presents outstanding challenges to science and medicine.NCT05769933·Bern

PreviousPage 165 of 212Next